Published Date: 05 Apr 2023
A new study led by a UCLA Health researcher found that pregnant women had a slightly increased risk of having children with autism spectrum disorder if the household tap water had higher lithium levels.
Read Full NewsRyan Donaghy, MD, an assistant professor of neurology at Northwestern Medicine, discussed the evolving landscape of ALS clinical trials, including advances in biomarkers, genetics, and modern trial design.
Vaishal Shah, MD, MPH, FAASM, FAAP, center director of the Sleep Disorders Center at Cleveland Clinic, spoke on the changes in how obstructive sleep apnea is treated, moving away from CPAP to more novel approaches.
In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing neuromyelitis optica spectrum disorder in Saudi Arabia.
Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.
Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers
Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study
Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy
1.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
2.
Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer
3.
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC
4.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
5.
Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
1.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
2.
The Link Between Being Overweight and Cancer
3.
Breaking Down Amyloidosis: Understanding the Disease
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Seeing the Unseen: Examining Chancroid Through Images
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation